Addex Therapeutics Ltd

NasdaqCM:ADXN Stock Report

Market Cap: US$8.4m

Addex Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ADXN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Aug 24SellUS$77,310New Enterprise Associates, Inc.Company9,000US$8.59

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ADXN?
Owner TypeNumber of SharesOwnership Percentage
Institutions3,903,0083.97%
Individual Insiders18,669,57119%
General Public31,876,06832.4%
Private Companies43,858,60344.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 19 shareholders own 67.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
44.6%
Addex Pharma S.A.
43,858,603US$3.8m0%no data
9.41%
Timothy Dyer
9,249,019US$794.0k-39.7%no data
3.06%
Robert Lutjens
3,005,836US$258.1k0%no data
2.58%
Jean-Philippe Rocher
2,541,197US$218.2k0%no data
2.55%
Vincent Lawton
2,507,987US$215.3k0%no data
1.62%
New Leaf Venture Partners, LLC
1,597,444US$137.1k0%0.15%
1.39%
Raymond Hill
1,365,532US$117.2k0%no data
0.73%
Caxton Associates LP
718,849US$61.7k0%no data
0.56%
UBS Asset Management AG
546,864US$46.9k0%no data
0.3%
Lombard Odier Asset Management (Switzerland) SA
296,761US$25.5k0%no data
0.18%
Morgan Stanley, Investment Banking and Brokerage Investments
180,000US$15.5k0%no data
0.16%
Herculis Partners SA
158,552US$13.6k0%0.17%
0.13%
ZKB Asset Management
124,940US$10.7k0%no data
0.11%
ADAR1 Capital Management, LLC
108,000US$9.3k131%no data
0.068%
Pictet Asset Management Limited
66,596US$5.7k0%no data
0.061%
BlackRock, Inc.
59,755US$5.1k5.58%no data
0.028%
LLB Asset Management AG
27,392US$2.4k0%no data
0.016%
Zürcher Kantonalbank, Investment Arm
15,792US$1.4k0%no data
0.0021%
Goldman Sachs Group, Investment Banking and Securities Investments
2,063US$177.20%no data